Latest news

MSWA Client Tracey Hockey’s philosophy to ‘never say never’ has seen her embrace every opportunity life has presented her with, including taking part in a cutting-edge stroke trial.

MSWA-funded researchers at Curtin University are developing a novel therapy approach for people with aphasia – a communication condition typically seen after stroke.

The Government has announced that ofatumumab (Kesimpta®) is now listed under the Pharmaceutical Benefit Scheme (PBS).

The MSWA Board has announced the appointment of new CEO Melanie Kiely, who will replace Marcus Stafford AM when he steps down in October.

Speech Pathology plays a crucial role in helping people regain a fundamental part of being human – communication. Speech Pathologists study, assess, and treat changes in understanding language, speaking, reading, writing, and importantly, swallowing food and drink.

Communication is a fundamental human right. Associate Professor Anne Whitworth from Curtin University is developing a new NARNIA Communication App to help people with communication issues after stroke. This is one of the newly funded projects from our record-breaking $10 million research contribution in 2021.

It is with sadness we advise that Dr Greg Brotherson passed away on Friday, 6 August 2021.

Over her 25 years as a volunteer, employee and Client, Caroline Clarke-Smith has seen MSWA’s presence in Albany grow from a small support group to the development of a $7m facility for people living with neurological conditions.

Aubagio (teriflunomide) a medication used to treat multiple sclerosis is being delisted in Australia by Sanfoli. Generic medications remain available.

Today, MSWA is proud to announce that in this 2021/22 financial year, we are committing a record-breaking amount of $10 million to neurological research.